• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构象可塑性增强了代谢稳定的双功能阿片肽环抗的脑穿透性。

Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAnt.

机构信息

College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.

Mass Spectrometry Facility, University of South Carolina, Columbia, SC 29208, USA.

出版信息

Int J Mol Sci. 2024 Oct 23;25(21):11389. doi: 10.3390/ijms252111389.

DOI:10.3390/ijms252111389
PMID:39518941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11546339/
Abstract

CycloAnt is an opioid peptide that produces potent and efficacious antinociception with significantly reduced side effects upon systemic administration in mice. To verify its CNS-mediated antinociception, we determined its binding affinity at the opioid receptors, its proteolytic stability in mouse serum, metabolic stability in mouse liver microsomes, and pharmacokinetics in mice. CycloAnt exhibited stability toward proteolytic degradation in serum and resistance against metabolism mediated by cytochrome P450 enzymes (CYP450s) and UDP-glucuronosyl transferases (UGTs) in mouse liver microsomes. A pharmacokinetic study of CycloAnt in mice confirmed that CycloAnt crossed the blood-brain barrier (BBB) with a brain-to-plasma ratio of 11.5%, a high extent of BBB transport for a peptide. To elucidate the structural basis underlying its BBB penetration, we investigated its conformation in water and DMSO using H NMR spectroscopy. The results show that CycloAnt displays an extended conformation in water with most amide NHs being exposed, while in less polar DMSO, it adopts a compact conformation with all amide NHs locked in intramolecular hydrogen bonds. The chameleonic property helps CycloAnt permeate the BBB.

摘要

环抗是一种阿片肽,在小鼠体内系统给药时具有强大而有效的镇痛作用,副作用明显减少。为了验证其中枢神经系统介导的镇痛作用,我们测定了其在阿片受体上的结合亲和力、在小鼠血清中的蛋白水解稳定性、在小鼠肝微粒体中的代谢稳定性以及在小鼠中的药代动力学。环抗在血清中对蛋白水解降解具有稳定性,并且在小鼠肝微粒体中对细胞色素 P450 酶 (CYP450s) 和 UDP-葡萄糖醛酸转移酶 (UGTs) 介导的代谢具有抗性。环抗在小鼠中的药代动力学研究证实,环抗能够穿过血脑屏障 (BBB),脑血浆比为 11.5%,这是一种肽类物质穿过 BBB 的高程度。为了阐明其穿透 BBB 的结构基础,我们使用 H NMR 光谱法研究了其在水中和 DMSO 中的构象。结果表明,环抗在水中呈现伸展构象,大多数酰胺 NH 暴露在外,而在极性较小的 DMSO 中,它采用紧凑构象,所有酰胺 NH 都被锁定在分子内氢键中。这种变色龙特性有助于环抗穿透 BBB。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/c894716649be/ijms-25-11389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/a927ad16fcc4/ijms-25-11389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/e1b784952fb3/ijms-25-11389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/cc70639730ff/ijms-25-11389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/6bac0bb2427c/ijms-25-11389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/c894716649be/ijms-25-11389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/a927ad16fcc4/ijms-25-11389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/e1b784952fb3/ijms-25-11389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/cc70639730ff/ijms-25-11389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/6bac0bb2427c/ijms-25-11389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb6f/11546339/c894716649be/ijms-25-11389-g005.jpg

相似文献

1
Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAnt.构象可塑性增强了代谢稳定的双功能阿片肽环抗的脑穿透性。
Int J Mol Sci. 2024 Oct 23;25(21):11389. doi: 10.3390/ijms252111389.
2
New trends in the development of opioid peptide analogues as advanced remedies for pain relief.阿片肽类似物作为先进止痛疗法的发展新趋势。
Curr Top Med Chem. 2004;4(1):19-38. doi: 10.2174/1568026043451663.
3
Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide.一种低风险抗伤害性双功能 MOR/DOR 环肽的鉴定和药理学特征。
Molecules. 2023 Nov 11;28(22):7548. doi: 10.3390/molecules28227548.
4
Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation.通过糖基化改善阿片肽的血脑屏障穿透能力并增强其镇痛作用。
J Pharmacol Exp Ther. 2001 Dec;299(3):967-72.
5
Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin.阿片受体激动剂双啡肽和孤啡肽的谷氨酸缓冲能力和血脑屏障保护作用。
J Pharmacol Exp Ther. 2021 Nov;379(3):260-269. doi: 10.1124/jpet.121.000831. Epub 2021 Oct 18.
6
In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist-neurokinin 1 receptor antagonist chimera.体内强效μ阿片受体激动剂四肽类似物的抗伤害作用及其与一种紧凑型阿片受体激动剂-神经激肽 1 受体拮抗剂嵌合体的比较。
Mol Brain. 2012 Jan 30;5:4. doi: 10.1186/1756-6606-5-4.
7
Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.螺旋约束型孤啡肽肽是阿片受体样受体1(ORL-1)和痛觉的强效激动剂和拮抗剂。
Vitam Horm. 2015;97:1-55. doi: 10.1016/bs.vh.2014.10.001. Epub 2015 Jan 14.
8
MEL-N16: A Series of Novel Endomorphin Analogs with Good Analgesic Activity and a Favorable Side Effect Profile.MEL-N16:一系列具有良好镇痛活性和有利副作用特征的新型内吗啡肽类似物。
ACS Chem Neurosci. 2017 Oct 18;8(10):2180-2193. doi: 10.1021/acschemneuro.7b00097. Epub 2017 Aug 10.
9
OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid/Neuropeptide FF Receptors with Improved Blood-Brain Barrier Penetration.OFP011 环状肽作为阿片/神经肽 FF 受体的多功能激动剂,具有改善的血脑屏障穿透性。
ACS Chem Neurosci. 2022 Nov 2;13(21):3078-3092. doi: 10.1021/acschemneuro.2c00442. Epub 2022 Oct 19.
10
Synthesis and Biological Characterization of Cyclic Disulfide-Containing Peptide Analogs of the Multifunctional Opioid/Neuropeptide FF Receptor Agonists That Produce Long-Lasting and Nontolerant Antinociception.具有多功能阿片/神经肽 FF 受体激动剂的环状二硫键肽类似物的合成与生物学特征,这些类似物产生持久且非耐受的镇痛作用。
J Med Chem. 2020 Dec 24;63(24):15709-15725. doi: 10.1021/acs.jmedchem.0c01367. Epub 2020 Dec 3.

本文引用的文献

1
Leading Causes of Death in the US, 2019-2023.2019 - 2023年美国的主要死因
JAMA. 2024 Sep 24;332(12):957-958. doi: 10.1001/jama.2024.15563.
2
Peptide-derived ligands for the discovery of safer opioid analgesics.用于发现更安全阿片类镇痛药的肽衍生配体。
Drug Discov Today. 2024 May;29(5):103950. doi: 10.1016/j.drudis.2024.103950. Epub 2024 Mar 20.
3
Vertex's non-opioid painkiller passes phase III tests.福泰公司的非阿片类止痛药通过了三期试验。
Nat Rev Drug Discov. 2024 Mar;23(3):162. doi: 10.1038/d41573-024-00029-z.
4
Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide.一种低风险抗伤害性双功能 MOR/DOR 环肽的鉴定和药理学特征。
Molecules. 2023 Nov 11;28(22):7548. doi: 10.3390/molecules28227548.
5
Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples.利用半胱氨酸订书钉对晚期功能化进行选择性肽 κ-阿片受体拮抗剂的开发。
J Med Chem. 2023 Sep 14;66(17):11843-11854. doi: 10.1021/acs.jmedchem.3c00426. Epub 2023 Aug 26.
6
Differential Blood-Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro.环肽在体内和体外的血脑屏障转运及细胞摄取差异
Pharmaceutics. 2023 May 16;15(5):1507. doi: 10.3390/pharmaceutics15051507.
7
Cell-permeable chameleonic peptides: Exploiting conformational dynamics in de novo cyclic peptide design.细胞渗透性变色龙肽:从头环肽设计中利用构象动力学。
Curr Opin Struct Biol. 2023 Jun;80:102603. doi: 10.1016/j.sbi.2023.102603. Epub 2023 May 12.
8
Accurate de novo design of membrane-traversing macrocycles.从头精准设计穿膜大环分子。
Cell. 2022 Sep 15;185(19):3520-3532.e26. doi: 10.1016/j.cell.2022.07.019. Epub 2022 Aug 29.
9
Therapeutic peptides: current applications and future directions.治疗性肽:当前的应用及未来方向。
Signal Transduct Target Ther. 2022 Feb 14;7(1):48. doi: 10.1038/s41392-022-00904-4.
10
Cyclosporin A: Conformational Complexity and Chameleonicity.环孢素 A:构象复杂性与变色龙特性。
J Chem Inf Model. 2021 Nov 22;61(11):5601-5613. doi: 10.1021/acs.jcim.1c00771. Epub 2021 Oct 21.